171 related articles for article (PubMed ID: 17197429)
41. Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent process.
Richardson DR
Biochim Biophys Acta; 1997 May; 1320(1):45-57. PubMed ID: 9186779
[TBL] [Abstract][Full Text] [Related]
42. Iron chelators deferoxamine and diethylenetriamine pentaacetic acid induce apoptosis in ovarian carcinoma.
Brard L; Granai CO; Swamy N
Gynecol Oncol; 2006 Jan; 100(1):116-27. PubMed ID: 16203029
[TBL] [Abstract][Full Text] [Related]
43. GSK3β-dependent cyclin D1 and cyclin E1 degradation is indispensable for NVP-BEZ235 induced G0/G1 arrest in neuroblastoma cells.
Liu SL; Liu Z; Zhang LD; Zhu HQ; Guo JH; Zhao M; Wu YL; Liu F; Gao FH
Cell Cycle; 2017; 16(24):2386-2395. PubMed ID: 28980866
[TBL] [Abstract][Full Text] [Related]
44. Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives.
Tsafack A; Loyevsky M; Ponka P; Cabantchik ZI
J Lab Clin Med; 1996 Jun; 127(6):574-82. PubMed ID: 8648262
[TBL] [Abstract][Full Text] [Related]
45. Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise: implications for iron-related dopaminergic neuron degeneration.
Zhou ZD; Lan YH; Tan EK; Lim TM
Free Radic Biol Med; 2010 Dec; 49(12):1856-71. PubMed ID: 20854902
[TBL] [Abstract][Full Text] [Related]
46. Deferoxamine inhibits iron-uptake stimulated osteoclast differentiation by suppressing electron transport chain and MAPKs signaling.
Zhang J; Hu W; Ding C; Yao G; Zhao H; Wu S
Toxicol Lett; 2019 Oct; 313():50-59. PubMed ID: 31238089
[TBL] [Abstract][Full Text] [Related]
47. Endosomal and lysosomal effects of desferrioxamine: protection of HeLa cells from hydrogen peroxide-induced DNA damage and induction of cell-cycle arrest.
Doulias PT; Christoforidis S; Brunk UT; Galaris D
Free Radic Biol Med; 2003 Oct; 35(7):719-28. PubMed ID: 14583336
[TBL] [Abstract][Full Text] [Related]
48. Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine.
Komoto K; Nomoto T; El Muttaqien S; Takemoto H; Matsui M; Miura Y; Nishiyama N
Cancer Sci; 2021 Jan; 112(1):410-421. PubMed ID: 32770631
[TBL] [Abstract][Full Text] [Related]
49. Regulation of IGF-1-dependent cyclin D1 and E expression by hEag1 channels in MCF-7 cells: the critical role of hEag1 channels in G1 phase progression.
Borowiec AS; Hague F; Gouilleux-Gruart V; Lassoued K; Ouadid-Ahidouch H
Biochim Biophys Acta; 2011 May; 1813(5):723-30. PubMed ID: 21315112
[TBL] [Abstract][Full Text] [Related]
50. Iron chelator-induced growth arrest and cytochrome c-dependent apoptosis in immortalized and malignant oral keratinocytes.
Lee SK; Lee JJ; Lee HJ; Lee J; Jeon BH; Jun CD; Lee SK; Kim EC
J Oral Pathol Med; 2006 Apr; 35(4):218-26. PubMed ID: 16519769
[TBL] [Abstract][Full Text] [Related]
51. The iron chelating agent, deferoxamine detoxifies Fe(Salen)-induced cytotoxicity.
Umemura M; Kim JH; Aoyama H; Hoshino Y; Fukumura H; Nakakaji R; Sato I; Ohtake M; Akimoto T; Narikawa M; Tanaka R; Fujita T; Yokoyama U; Taguri M; Okumura S; Sato M; Eguchi H; Ishikawa Y
J Pharmacol Sci; 2017 Aug; 134(4):203-210. PubMed ID: 28779994
[TBL] [Abstract][Full Text] [Related]
52. Iron chelators ICL670 and 311 inhibit HIV-1 transcription.
Debebe Z; Ammosova T; Jerebtsova M; Kurantsin-Mills J; Niu X; Charles S; Richardson DR; Ray PE; Gordeuk VR; Nekhai S
Virology; 2007 Oct; 367(2):324-33. PubMed ID: 17631934
[TBL] [Abstract][Full Text] [Related]
53. Mitochondrial dysfunction via disruption of complex II activity during iron chelation-induced senescence-like growth arrest of Chang cells.
Yoon YS; Cho H; Lee JH; Yoon G
Ann N Y Acad Sci; 2004 Apr; 1011():123-32. PubMed ID: 15126290
[TBL] [Abstract][Full Text] [Related]
54. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
55. NBM-T-BBX-OS01, Semisynthesized from Osthole, Induced G1 Growth Arrest through HDAC6 Inhibition in Lung Cancer Cells.
Pai JT; Hsu CY; Hua KT; Yu SY; Huang CY; Chen CN; Liao CH; Weng MS
Molecules; 2015 May; 20(5):8000-19. PubMed ID: 25946558
[TBL] [Abstract][Full Text] [Related]
56. Antiproliferative and apoptotic effects of O-Trensox, a new synthetic iron chelator, on differentiated human hepatoma cell lines.
Rakba N; Loyer P; Gilot D; Delcros JG; Glaise D; Baret P; Pierre JL; Brissot P; Lescoat G
Carcinogenesis; 2000 May; 21(5):943-51. PubMed ID: 10783316
[TBL] [Abstract][Full Text] [Related]
57. Iron chelator triggers inflammatory signals in human intestinal epithelial cells: involvement of p38 and extracellular signal-regulated kinase signaling pathways.
Choi EY; Kim EC; Oh HM; Kim S; Lee HJ; Cho EY; Yoon KH; Kim EA; Han WC; Choi SC; Hwang JY; Park C; Oh BS; Kim Y; Kimm KC; Park KI; Chung HT; Jun CD
J Immunol; 2004 Jun; 172(11):7069-77. PubMed ID: 15153529
[TBL] [Abstract][Full Text] [Related]
58. Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in human colorectal cancer cells.
Eo HJ; Park GH; Song HM; Lee JW; Kim MK; Lee MH; Lee JR; Koo JS; Jeong JB
Int Immunopharmacol; 2015 Jan; 24(1):1-6. PubMed ID: 25479723
[TBL] [Abstract][Full Text] [Related]
59. Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture.
Baker E; Vitolo ML; Webb J
Biochem Pharmacol; 1985 Sep; 34(17):3011-7. PubMed ID: 4038321
[TBL] [Abstract][Full Text] [Related]
60. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.
Williamson EA; Burgess GS; Eder P; Litz-Jackson S; Boswell HS
Leukemia; 1997 Jan; 11(1):73-85. PubMed ID: 9001421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
